| Literature DB >> 18995920 |
.
Abstract
Self-monitoring of blood glucose (SMBG) in type 2 diabetic patients was compared across 14 countries. There was an unexpectedly high SMBG-use in non-insulin-treated patients. Reimbursement polices differed by country, region, insurance status, and patient income. More rigorous and systematic data collection is needed to ensure evidence-based SMBG-use.Entities:
Mesh:
Year: 2008 PMID: 18995920 PMCID: PMC4319544 DOI: 10.1016/j.diabres.2008.08.021
Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN: 0168-8227 Impact factor: 5.602